A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma

Collectively, hematological malignancies account for the fourth most common malignancy. Myeloma and lymphoma are the most common types of hematological malignancies. Unfortunately, the management of refractory myeloma and lymphoma remains challenging. The discovery of new immunological therapies, na...

Descripción completa

Detalles Bibliográficos
Autores principales: Atrash, Shebli, Moyo, Tamara K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009535/
https://www.ncbi.nlm.nih.gov/pubmed/33814917
http://dx.doi.org/10.2147/OTT.S242018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009535/
https://www.ncbi.nlm.nih.gov/pubmed/33814917
http://dx.doi.org/10.2147/OTT.S242018

Ejemplares similares